AIM ImmunoTech (AIM) Board Issues Letter to Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
AIM ImmunoTech Board Issues Letter to Shareholders
October 26, 2022 5:12 PM EDTCorrects the Record Regarding Activist Groups False and Misleading Statements
Highlights Evidence of Groups Scheme to Have Jorgl Serve as the Face of the Activist to Help Them Get Control Without Paying a Premium to All Shareholders
Group Concealed that Its Campaign Was Orchestrated by One Convicted Felon and Financed by Another Criminal Until Forced to Do So in Context of Litigation
Urges Shareholders to Continue to Support Companys Positive Momentum Towards Value Creation by Voting on the WHITE Proxy Card to... More



